MedMen: what went wrong at the cannabis industry’s first unicorn, with Founder and former CEO Adam Bierman

MedMen: what went wrong at the cannabis industry’s first unicorn, with Founder and former CEO Adam Bierman

By Kindling Media

Look, we’re going to tell you straight - this is a blinding episode - and that’s because we’re talking to a man who is unflinchingly honest about his Founder experience. On the outside it looked like Adam Bierman had it all. He was the Co-Founder and CEO of MedMen, a cult phenomenon and the world’s first cannabis unicorn. They were seen as the Apple of weed and they looked unstoppable.  But in 2019, a year after hitting its all time high on the Canadian stock market, the company had lost 95% of its value. Adam’s personal wealth was also up in smoke because he hadn’t listened to his advisors - instead of diversifying his assets, he’d bought even more MedMen stock. And then came the lawsuits. Adam is no longer with the company and was in a reflective mood when he sat down with Dan. So what on earth happened? Why did he leave the company? And what has he learnt from all of this?  -- Sponsors Vorboss - get better internet: https://vorboss.com/secretleaders Vanta - get 20% off security certifications like ISO27001 and SOC2: https://vanta.com/secretleaders Vertice - save on your SaaS or cloud spend ($5k off or a free benchmark) using the code secretleaders: https://www.vertice.one/l/secretleaders -- Newsletter Sign up here: https://secretleaders.email/ You can find our historic newsletters here: https://www.secretleaders.com/episodes
-
-
Heart UK
Mute/Un-mute